With funding secured, the trial is expected to begin in early 2020.
According to a new review of scientific studies, there is barely any evidence to suggest that cannabinoids can treat depression, anxiety, and other mental health disorders.
Discussing the ins and outs of Canada’s cannabis testing industry, Analytical Cannabis spoke to Dr Kaveh Kahen, CEO of Sigma Analytical Services, a Toronto-based provider of testing, research, and product development services to the cannabis industry.
A new systematic review concluded that medical cannabis may provide some benefit in reducing opioid misuse, but more research will be needed before it can be recommended as a safe alternative.
A report from the first ever workshop dedicated to measuring heavy metals in cannabis and hemp.
While people generally understand the dangers associated with alcohol and pregnancy, they may be far less skeptical about the safety of CBD products.
They're the commonly used form of cannabis in the US, but as edibles are likely to be exposed to processing chemicals during their production, each product needs to be tested for dangerous residual solvents.
Public curiosity in CBD appears to be higher than ever.
While regulators advise consumers to avoid all THC vaping products, new studies from cannabis labs indicate that the real problem could be the black market.